Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT): A Prospective Real-World Cohort Study in the Qinghai-Tibet Plateau

NCT07205523 is registered in ClinicalTrials.gov with Yigeng Cao,MD,PhD as lead sponsor.

NCT NCT07205523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07205523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT): A Prospective Real-World Cohort Study in the Qinghai-Tibet Plateau
Lead sponsor
Yigeng Cao,MD,PhD
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2023
Completion date
December 31, 2100
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), aplastic anemia, bleeding disorders, bone marrow transplantation, hematopoietic stem cell transplantation (hsct), hemophilia, immune reconstitution, leukemia, leukemias, acute myeloid, lymphoma, mds, multiple myeloma, myelodysplastic syndrome, myeloid leukemias, acute, myeloma, multiple